BioNTech SE (BNTX) Current Assets (2018 - 2024)
BioNTech SE's Current Assets history spans 7 years, with the latest figure at $20.1 billion for Q4 2024.
- For Q4 2024, Current Assets rose 636.8% year-over-year to $20.1 billion; the TTM value through Dec 2024 reached $20.1 billion, changed N/A, while the annual FY2024 figure was $20.4 billion, 640.8% up from the prior year.
- Current Assets for Q4 2024 was $20.1 billion at BioNTech SE, up from -$3.7 billion in the prior quarter.
- Across five years, Current Assets topped out at $20.1 billion in Q4 2024 and bottomed at -$3.7 billion in Q4 2023.
- The 5-year median for Current Assets is $2.0 billion (2020), against an average of $6.8 billion.
- The largest annual shift saw Current Assets soared 767.57% in 2021 before it plummeted 170.35% in 2023.
- A 5-year view of Current Assets shows it stood at $2.0 billion in 2020, then skyrocketed by 767.57% to $17.2 billion in 2021, then crashed by 108.03% to -$1.4 billion in 2022, then crashed by 170.35% to -$3.7 billion in 2023, then skyrocketed by 636.8% to $20.1 billion in 2024.
- Per Business Quant, the three most recent readings for BNTX's Current Assets are $20.1 billion (Q4 2024), -$3.7 billion (Q4 2023), and -$1.4 billion (Q4 2022).